BBT Capital Management’s Medifast MED Stock Holding History

BBT Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,068	Closed	-$265K	–	84
2019 Q2	$265K	Buy	+2,068	New	+$287K	0.31%	137

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBT Capital Management's MED Position: Q3 2019 in Review

BBT Capital Management sold out of Medifast (MED) in Q3 2019, closing a stake of 2,068 shares — an estimated $265K sold.

BBT Capital Management first reported a position in MED in Q2 2019 and held it in 1 quarter. The position peaked at $265K in Q2 2019. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

BBT Capital Management reported no remaining Medifast position as of Q3 2019 after selling out during the quarter.
BBT Capital Management sold 2,068 Medifast shares in Q3 2019, an estimated $265K.
BBT Capital Management first reported a position in Medifast in Q2 2019 and held it in 1 quarter.
BBT Capital Management's Medifast position peaked at $265K in Q2 2019.
239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on BBT Capital Management's 13F filing for Q3 2019.